ANI Pharmaceuticals Inc ANIP:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/25/21 EST
29.60quote price arrow down-0.18 (-0.60%)
Volume
55,222
52 week range
23.55 - 59.50

...

Loading . . .

KEY STATS

  • Open29.78
  • Day High30.35
  • Day Low29.05
  • Prev Close29.60
  • 52 Week High59.50
  • 52 Week High Date02/26/20
  • 52 Week Low23.55
  • 52 Week Low Date11/06/20
  • Market Cap365.86M
  • Shares Out12.36M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • 1 Year % Change-48.71

RATIOS/PROFITABILITY

  • EPS (TTM)-1.99
  • P/E (TTM)-14.90
  • Fwd P/E (NTM)7.89
  • EBITDA (MRQ)37.301M
  • ROE (MRQ)-11.60%
  • Revenue (MRQ)199.19M
  • Gross Margin (MRQ)59.63%
  • Net Margin (MRQ)-11.92%
  • Debt To Equity (MRQ)96.33%

EVENTS

  • Earnings Date03/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ANI Pharmaceuticals Inc News

There is no recent news for this security.

Latest ANIP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its...
Patrick Walsh
Chairman
Nikhil Lalwani
President
Stephen Carey
Chief Financial Officer
Address
210 W Main St
Baudette, MN
56623-2467
United States